TABLE 1.
SCp2–Id-1 cells are not tumorigenica
| Cell type | No. of tumors/no. of sites injected (time) |
|---|---|
| TCL1 | 4/4 (after 3 wk) |
| SCg6 | 4/4 (after 3 wk) |
| SCp2 | 0/4 (after 5 mo) |
| SCp2–antisense Id-1 | 0/4 (after 5 mo) |
| SCp2–Id-1 | 0/4 (after 5 mo) |
Cells (4 × 106 per site) were injected into two sites per animal, and two animals were used for each cell type, as described in Materials and Methods. The tumors that developed were at least 1 cm3.